<?xml version="1.0" encoding="UTF-8" standalone="no"?><ContractNotice xmlns="urn:oasis:names:specification:ubl:schema:xsd:ContractNotice-2" xmlns:cac="urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2" xmlns:cbc="urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2" xmlns:efac="http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1" xmlns:efbc="http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1" xmlns:efext="http://data.europa.eu/p27/eforms-ubl-extensions/1" xmlns:ext="urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2">
   <ext:UBLExtensions>
      <ext:UBLExtension>
         <ext:ExtensionContent>
            <efext:EformsExtension>
               <efac:NoticeSubType>
                  <cbc:SubTypeCode listName="notice-subtype">16</cbc:SubTypeCode>
               </efac:NoticeSubType>
               <efac:Organizations>
                  <efac:Organization>
                     <efac:Company>
                        <cbc:WebsiteURI>www.evaggelismos-hosp.gr</cbc:WebsiteURI>
                        <cac:PartyIdentification>
                           <cbc:ID schemeName="organization">ORG-0001</cbc:ID>
                        </cac:PartyIdentification>
                        <cac:PartyName>
                           <cbc:Name languageID="ELL">ΓΝΑ Ο ΕΥΑΓΓΕΛΙΣΜΟΣ - ΠΟΛΥΚΛΙΝΙΚΗ</cbc:Name>
                        </cac:PartyName>
                        <cac:PostalAddress>
                           <cbc:StreetName>ΥΨΗΛΑΝΤΟΥ 45-47</cbc:StreetName>
                           <cbc:CityName>ΑΘΗΝΑ</cbc:CityName>
                           <cbc:PostalZone>10676</cbc:PostalZone>
                           <cbc:CountrySubentityCode listName="nuts">EL303</cbc:CountrySubentityCode>
                           <cac:Country>
                              <cbc:IdentificationCode listName="country">GRC</cbc:IdentificationCode>
                           </cac:Country>
                        </cac:PostalAddress>
                        <cac:PartyLegalEntity>
                           <cbc:CompanyID>1015.Ε00159.0001</cbc:CompanyID>
                        </cac:PartyLegalEntity>
                        <cac:Contact>
                           <cbc:Name>ΕΛΕΝΗ ΚΑΨΑ</cbc:Name>
                           <cbc:Telephone>213 204 1773</cbc:Telephone>
                           <cbc:ElectronicMail>promithies@evaggelismos-hosp.gr</cbc:ElectronicMail>
                        </cac:Contact>
                     </efac:Company>
                  </efac:Organization>
                  <efac:Organization>
                     <efac:Company>
                        <cbc:WebsiteURI>www.aepp-procurement.gr</cbc:WebsiteURI>
                        <cac:PartyIdentification>
                           <cbc:ID schemeName="organization">ORG-0002</cbc:ID>
                        </cac:PartyIdentification>
                        <cac:PartyName>
                           <cbc:Name languageID="ELL">ΕΝΙΑΙΑ ΑΡΧΗ ΔΗΜΟΣΙΩΝ ΣΥΜΒΑΣΕΩΝ</cbc:Name>
                        </cac:PartyName>
                        <cac:PostalAddress>
                           <cbc:StreetName>ΔΩΡΟΥ 7 -9 </cbc:StreetName>
                           <cbc:CityName>ΑΘΗΝΑ</cbc:CityName>
                           <cbc:PostalZone>10432</cbc:PostalZone>
                           <cbc:CountrySubentityCode listName="nuts">EL303</cbc:CountrySubentityCode>
                           <cac:Country>
                              <cbc:IdentificationCode listName="country">GRC</cbc:IdentificationCode>
                           </cac:Country>
                        </cac:PostalAddress>
                        <cac:PartyLegalEntity>
                           <cbc:CompanyID>1000.Ε00961.0001</cbc:CompanyID>
                        </cac:PartyLegalEntity>
                        <cac:Contact>
                           <cbc:Name>ΕΑΔΗΣΥ</cbc:Name>
                           <cbc:Telephone>213 214 1227</cbc:Telephone>
                           <cbc:ElectronicMail>grafeioproedrou@aepp-procurement.gr</cbc:ElectronicMail>
                        </cac:Contact>
                     </efac:Company>
                  </efac:Organization>
                  <efac:Organization>
                     <efac:Company>
                        <cbc:WebsiteURI>https://op.europa.eu</cbc:WebsiteURI>
                        <cac:PartyIdentification>
                           <cbc:ID schemeName="organization">ORG-0000</cbc:ID>
                        </cac:PartyIdentification>
                        <cac:PartyName>
                           <cbc:Name languageID="ELL">Publications Office of the European Union</cbc:Name>
                        </cac:PartyName>
                        <cac:PostalAddress>
                           <cbc:CityName>Luxembourg</cbc:CityName>
                           <cbc:PostalZone>2417</cbc:PostalZone>
                           <cbc:CountrySubentityCode listName="nuts">LU000</cbc:CountrySubentityCode>
                           <cac:Country>
                              <cbc:IdentificationCode listName="country">LUX</cbc:IdentificationCode>
                           </cac:Country>
                        </cac:PostalAddress>
                        <cac:PartyLegalEntity>
                           <cbc:CompanyID>PUBL</cbc:CompanyID>
                        </cac:PartyLegalEntity>
                        <cac:Contact>
                           <cbc:Telephone>+352 29291</cbc:Telephone>
                           <cbc:ElectronicMail>ted@publications.europa.eu</cbc:ElectronicMail>
                        </cac:Contact>
                     </efac:Company>
                  </efac:Organization>
               </efac:Organizations>
            <efac:Publication><efbc:NoticePublicationID schemeName="ojs-notice-id">00526920-2025</efbc:NoticePublicationID><efbc:GazetteID schemeName="ojs-id">153/2025</efbc:GazetteID><efbc:PublicationDate>2025-08-12+02:00</efbc:PublicationDate></efac:Publication></efext:EformsExtension>
         </ext:ExtensionContent>
      </ext:UBLExtension>
   </ext:UBLExtensions>
   <cbc:UBLVersionID>2.3</cbc:UBLVersionID>
   <cbc:CustomizationID>eforms-sdk-1.13</cbc:CustomizationID>
   <cbc:ID schemeName="notice-id">93f8dc3f-a709-4431-95bc-8a01ffc40dac</cbc:ID>
   <cbc:ContractFolderID>4086fb78-5600-4583-9d5e-362f1bdc7998</cbc:ContractFolderID>
   <cbc:IssueDate>2025-08-11Z</cbc:IssueDate>
   <cbc:IssueTime>07:43:28Z</cbc:IssueTime>
   <cbc:VersionID>01</cbc:VersionID>
   <cbc:RegulatoryDomain>32014L0024</cbc:RegulatoryDomain>
   <cbc:NoticeTypeCode listName="competition">cn-standard</cbc:NoticeTypeCode>
   <cbc:NoticeLanguageCode listName="language">ELL</cbc:NoticeLanguageCode>
   <cac:ContractingParty>
      <cac:ContractingPartyType>
         <cbc:PartyTypeCode listName="buyer-legal-type">body-pl</cbc:PartyTypeCode>
      </cac:ContractingPartyType>
      <cac:ContractingActivity>
         <cbc:ActivityTypeCode listName="authority-activity">health</cbc:ActivityTypeCode>
      </cac:ContractingActivity>
      <cac:Party>
         <cac:PartyIdentification>
            <cbc:ID schemeName="organization">ORG-0001</cbc:ID>
         </cac:PartyIdentification>
         <cac:ServiceProviderParty>
            <cbc:ServiceTypeCode listName="organisation-role">ted-esen</cbc:ServiceTypeCode>
            <cac:Party>
               <cac:PartyIdentification>
                  <cbc:ID schemeName="organization">ORG-0000</cbc:ID>
               </cac:PartyIdentification>
            </cac:Party>
         </cac:ServiceProviderParty>
      </cac:Party>
   </cac:ContractingParty>
   <cac:TenderingTerms>
      <cac:TendererQualificationRequest>
         <cac:SpecificTendererRequirement>
            <cbc:TendererRequirementTypeCode listName="exclusion-grounds-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
         </cac:SpecificTendererRequirement>
      </cac:TendererQualificationRequest>
      <cac:LotDistribution>
         <cbc:MaximumLotsAwardedNumeric>4</cbc:MaximumLotsAwardedNumeric>
         <cbc:MaximumLotsSubmittedNumeric>4</cbc:MaximumLotsSubmittedNumeric>
      </cac:LotDistribution>
   </cac:TenderingTerms>
   <cac:TenderingProcess>
      <cbc:ProcedureCode listName="procurement-procedure-type">open</cbc:ProcedureCode>
      <cac:ProcessJustification>
         <cbc:ProcessReasonCode listName="accelerated-procedure">false</cbc:ProcessReasonCode>
      </cac:ProcessJustification>
   </cac:TenderingProcess>
   <cac:ProcurementProject>
      <cbc:Name languageID="ELL">ΠΡΟΜΗΘΕΙΑ ΑΝΤΙΣΩΜΑΤΩΝ ΚΑΙ ΑΝΤΙΔΡΑΣΤΗΡΙΩΝ ΧΩΡΙΣ ΣΥΝΟΔΟ ΕΞΟΠΛΙΣΜΟ ΓΙΑ ΤΟ ΠΑΘΟΛΟΓΟΑΝΑΤΟΜΙΚΟ ΤΜΗΜΑ ΤΟΥ Γ.Ν.Α. Ο ΕΥΑΓΓΕΛΙΣΜΟΣ-ΠΟΛΥΚΛΙΝΙΚΗ ΝΠΔΔ</cbc:Name>
      <cbc:Description languageID="ELL">ΠΡΟΜΗΘΕΙΑ ΑΝΤΙΣΩΜΑΤΩΝ ΚΑΙ ΑΝΤΙΔΡΑΣΤΗΡΙΩΝ ΧΩΡΙΣ ΣΥΝΟΔΟ ΕΞΟΠΛΙΣΜΟ ΓΙΑ ΤΟ ΠΑΘΟΛΟΓΟΑΝΑΤΟΜΙΚΟ ΤΜΗΜΑ ΤΟΥ Γ.Ν.Α. Ο ΕΥΑΓΓΕΛΙΣΜΟΣ-ΠΟΛΥΚΛΙΝΙΚΗ ΝΠΔΔ</cbc:Description>
      <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
      <cac:RequestedTenderTotal>
         <cbc:EstimatedOverallContractAmount currencyID="EUR">2160167</cbc:EstimatedOverallContractAmount>
      </cac:RequestedTenderTotal>
      <cac:MainCommodityClassification>
         <cbc:ItemClassificationCode listName="cpv">33696500</cbc:ItemClassificationCode>
      </cac:MainCommodityClassification>
      <cac:RealizedLocation>
         <cac:Address>
            <cbc:CountrySubentityCode listName="nuts">EL303</cbc:CountrySubentityCode>
            <cac:Country>
               <cbc:IdentificationCode listName="country">GRC</cbc:IdentificationCode>
            </cac:Country>
         </cac:Address>
      </cac:RealizedLocation>
   </cac:ProcurementProject>
   <cac:ProcurementProjectLot>
      <cbc:ID schemeName="Lot">LOT-0001</cbc:ID>
      <cac:TenderingTerms>
         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
         <cac:CallForTendersDocumentReference>
            <cbc:ID>Α/Α 378623</cbc:ID>
            <cbc:DocumentType>non-restricted-document</cbc:DocumentType>
            <cac:Attachment>
               <cac:ExternalReference>
                  <cbc:URI>https://nepps-search.eprocurement.gov.gr/actSearch/resources/search/378623</cbc:URI>
               </cac:ExternalReference>
            </cac:Attachment>
         </cac:CallForTendersDocumentReference>
         <cac:TendererQualificationRequest>
            <cac:SpecificTendererRequirement>
               <cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
            </cac:SpecificTendererRequirement>
         </cac:TendererQualificationRequest>
         <cac:TendererQualificationRequest>
            <cac:SpecificTendererRequirement>
               <cbc:TendererRequirementTypeCode listName="reserved-procurement">none</cbc:TendererRequirementTypeCode>
            </cac:SpecificTendererRequirement>
         </cac:TendererQualificationRequest>
         <cac:ContractExecutionRequirement>
            <cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
         </cac:ContractExecutionRequirement>
         <cac:ContractExecutionRequirement>
            <cbc:ExecutionRequirementCode listName="einvoicing">required</cbc:ExecutionRequirementCode>
         </cac:ContractExecutionRequirement>
         <cac:ContractExecutionRequirement>
            <cbc:ExecutionRequirementCode listName="ecatalog-submission">not-allowed</cbc:ExecutionRequirementCode>
         </cac:ContractExecutionRequirement>
         <cac:AwardingTerms>
            <cac:AwardingCriterion>
               <cbc:CalculationExpression languageID="ELL">ΚΡΙΤΗΡΙΟ ΚΑΤΑΚΥΡΩΣΗΣ ΕΙΝΑΙ Η ΧΑΜΗΛΟΤΕΡΗ ΤΙΜΗ</cbc:CalculationExpression>
               <cac:SubordinateAwardingCriterion>
                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
                  <cbc:Description languageID="ELL">ΚΡΙΤΗΡΙΟ ΚΑΤΑΚΥΡΩΣΗΣ ΕΙΝΑΙ Η ΧΑΜΗΛΟΤΕΡΗ ΤΙΜΗ</cbc:Description>
               </cac:SubordinateAwardingCriterion>
            </cac:AwardingCriterion>
         </cac:AwardingTerms>
         <cac:TenderRecipientParty>
            <cbc:EndpointID>https://portal.eprocurement.gov.gr/webcenter/portal/TestPortal</cbc:EndpointID>
         </cac:TenderRecipientParty>
         <cac:TenderValidityPeriod>
            <cbc:DurationMeasure unitCode="MONTH">12</cbc:DurationMeasure>
         </cac:TenderValidityPeriod>
         <cac:AppealTerms>
            <cac:AppealInformationParty>
               <cac:PartyIdentification>
                  <cbc:ID>ORG-0001</cbc:ID>
               </cac:PartyIdentification>
            </cac:AppealInformationParty>
            <cac:AppealReceiverParty>
               <cac:PartyIdentification>
                  <cbc:ID>ORG-0002</cbc:ID>
               </cac:PartyIdentification>
            </cac:AppealReceiverParty>
         </cac:AppealTerms>
         <cac:Language>
            <cbc:ID>ELL</cbc:ID>
         </cac:Language>
         <cac:PostAwardProcess>
            <cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
            <cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
         </cac:PostAwardProcess>
      </cac:TenderingTerms>
      <cac:TenderingProcess>
         <cbc:SubmissionMethodCode listName="esubmission">required</cbc:SubmissionMethodCode>
         <cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
         <cac:TenderSubmissionDeadlinePeriod>
            <cbc:EndDate>2025-09-26+03:00</cbc:EndDate>
            <cbc:EndTime>15:00:00+03:00</cbc:EndTime>
         </cac:TenderSubmissionDeadlinePeriod>
         <cac:OpenTenderEvent>
            <cbc:OccurrenceDate>2025-09-29+03:00</cbc:OccurrenceDate>
            <cbc:OccurrenceTime>10:00:00+03:00</cbc:OccurrenceTime>
         </cac:OpenTenderEvent>
         <cac:AuctionTerms>
            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
         </cac:AuctionTerms>
         <cac:ContractingSystem>
            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
         </cac:ContractingSystem>
         <cac:ContractingSystem>
            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
         </cac:ContractingSystem>
      </cac:TenderingProcess>
      <cac:ProcurementProject>
         <cbc:Name languageID="ELL">ΤΜΗΜΑΤΑ ΑΠΟ 1 - 100 </cbc:Name>
         <cbc:Description languageID="ELL">ΤΜΗΜΑ - ΠΕΡΙΓΡΑΦΗ 
1	MOUSE ANTI HUMAN IGF2 (8H1)
2	MOUSE ANTI HUMAN TOXOPLASMA
3	MOUSE ANTI HUMAN FOSB 
4	MOUSE ANTI HUMAN CARBONIC ANHYDRASE 9
5	MOUSE ANTI HUMAN CD1α
6	MOUSE ANTI HUMAN CD82
7	MOUSE ANTI HUMAN GCET-1
8	MOUSE ANTI HUMAN CYTOKERATIN AE1/AE3
9	MOUSE ANTI HUMAN EGFR
10	MOUSE ANTI HUMAN FASCIN
11	MOUSE ANTI HUMAN PAN TRK
12	MOUSE ANTI HUMAN FSH beta
13	MOUSE ANTI HUMAN GLUCAGON
14	MOUSE ANTI HUMAN GLYCOPHORIN A
15	MOUSE ANTI HUMAN HLA DP,DQ,DR  (CR3/43)
16	MOUSE ANTI HUMAN INSULIN
17	MOUSE ANTI HUMAN ISLET-1
18	MOUSE ANTI HUMAN LMO2
19	RABBIT ANTI HUMAN LYSOZYME
20	MOUSE  ANTI HUMAN MYOGENIN
21	MOUSE ANTI HUMAN NAPSIN A
22	MOUSE  ANTI HUMAN NKX3,1
23	MOUSE ANTI HUMAN OCT3/4
24	MOUSE ANTI HUMAN P120-
25	RABBIT ANTI HUMAN PGP9.5-
26	MOUSE ANTI HUMAN PROLACTIN
27	MOUSE ANTI HUMAN PSMA-
28	MOUSE ANTI HUMAN PTH
29	MOUSE ANTI HUMAN SALL4
30	MOUSE ANTI HUMAN TCRbeta
31	MOUSE ANTI HUMAN TLE1
32	MOUSE ANTI HUMAN WT1
33	MOUSE ANTI HUMAN ANTI-HISTONE H3.3 G34R
34	MOUSE ANTI HUMAN ACTH
35	MOUSE ANTI HUMAN SIMIAN VACUOLATING VIRUS  SV-40
36	RABBIT ANTI HUMAN C1q/FITC
37	RABBIT ANTI HUMAN ALK D5F3
38	MOUSE ANTI HUMAN ALK PROTEIN (ALK1)
39	RABBIT ANTI HUMAN ALPHA-1 ANTICHYMOTRYPSIN
40	RABBIT ANTI HUMAN ALPHA-1 ANTITRYPSIN
41	MOUSE ANTI HUMAN ALPHA-1 FETOPROTEIN
42	MOUSE ANTI HUMAN bcl-10 (bcl-10/411)
43	MOUSE ANTI HUMAN NRAS(Q61)
44	MOUSE ANTI HUMAN ANDROGEN  RECEPTOR
45	MOUSE ANTI HUMAN ANNEXIN-A1
46	MOUSE ANTI HUMAN ATRX
47	MOUSE ANTI HUMAN BCL-2
48	MOUSE ANTI HUMAN BCL-2 (E17 )
49	MOUSE ANTI HUMAN BCL-6
50	MOUSE ANTI HUMAN BCL-10 (331.3)
51	MOUSE ANTI HUMAN BETA-CATENIN
52	MOUSE ANTI HUMAN POU2F3 (6D1)
53	MOUSE ANTI HUMAN BOB.1
54	RABBIT ANTI HUMAN C4d
55	MOUSE ANTI HUMAN CA19-9
56	MOUSE ANTI HUMAN CA125
57	MOUSE ANTI HUMAN CALCITONIN
58	MOUSE ANTI HUMAN CALPONIN
59	MOUSE ANTI HUMAN CALRETININ
60	MOUSE ANTI HUMAN CD2
61	MOUSE ANTI HUMAN ANTI-HISTONE H3.3 G34W
62	RABBIT ANTI HUMAN CD3
63	MOUSE ANTI HUMAN HSP-70
64	MOUSE ANTI HUMAN CD4
65	MOUSE ANTI HUMAN CD5
66	MOUSE ANTI HUMAN CD7
67	MOUSE ANTI HUMAN CD8
68	MOUSE ANTI HUMAN CD10 (56C6)
69	MOUSE  ANTI HUMAN CD11c
70	MOUSE ANTI HUMAN CD13
71	MOUSE ANTI HUMAN CD14
72	MOUSE ANTI HUMAN CD15
73	MOUSE ANTI HUMAN CD19
74	MOUSE ANTI HUMAN CD20 (L26)
75	MOUSE ANTI HUMAN CD21
76	MOUSE ANTI HUMAN ARID1A
77	MOUSE ANTI HUMAN CD23
78	MOUSE ANTI HUMAN CD25
79	MOUSE ANTI HUMAN CD30 (Ber-H2)
80	MOUSE ANTI HUMAN CD31 (JC70A)
81	MOUSE ANTI HUMAN CD33
82	MOUSE ANTI HUMAN CD34 (QBEnd10)
83	MOUSE ANTI HUMAN CD35 (Ber-MAC-DRC)
84	MOUSE ANTI HUMAN CD38
85	MOUSE ANTI HUMAN CD44
86	MOUSE ANTI HUMAN CD43
87	MOUSE ANTI HUMAN CD45RO (UCHL1)
88	MOUSE ANTI HUMAN CD56 (123C3)
89	MOUSE ANTI HUMAN CD57
90	MOUSE ANTI HUMAN CD61 ( 2f2 )
91	MOUSE ANTI HUMAN CD68 (KP1)
92	MOUSE ANTI HUMAN CD68 (PG-M1)
93	MOUSE ANTI HUMAN CD79A
94	MOUSE ANTI HUMAN CD99 MIC2
95	MOUSE ANTI HUMAN DNAjB9
96	MOUSE ANTI HUMAN CD123
97	MOUSE ANTI HUMAN CD138
98	MOUSE ANTI HUMAN CD163
99	MOUSE ANTI HUMAN CDX2
100	MOUSE ANTI HUMAN CEA
 ΣΥΝΟΛΟ ΠΡΟ Φ.Π.Α. 
1	6.000,00  €
2	1.100,00  €
3	2.800,00  €
4	2.000,00  €
5	1.800,00  €
6	2.400,00  €
7	4.800,00  €
8	2.800,00  €
9	6.600,00  €
10	1.100,00  €
11	3.600,00  €
12	1.800,00  €
13	1.800,00  €
14	700,00  €
15	3.000,00  €
16	1.800,00  €
17	7.200,00  €
18	2.400,00  €
19	500,00  €
20	1.000,00  €
21	4.000,00  €
22	3.300,00  €
23	2.200,00  €
24	3.300,00  €
25	900,00  €
26	2.000,00  €
27	1.200,00  €
28	900,00  €
29	6.000,00  €
30	2.400,00  €
31	3.600,00  €
32	2.400,00  €
33	11.200,00  €
34	2.200,00  €
35	2.400,00  €
36	2.000,00  €
37	4.000,00  €
38	3.300,00  €
39	500,00  €
40	500,00  €
41	1.400,00  €
42	4.200,00  €
43	10.000,00  €
44	2.000,00  €
45	2.400,00  €
46	7.200,00  €
47	3.600,00  €
48	2.400,00  €
49	6.000,00  €
50	2.400,00  €
51	3.300,00  €
52	2.400,00  €
53	1.200,00  €
54	4.800,00  €
55	1.800,00  €
56	1.800,00  €
57	1.600,00  €
58	1.800,00  €
59	2.700,00  €
60	2.700,00  €
61	9.000,00  €
62	4.000,00  €
63	3.000,00  €
64	4.400,00  €
65	4.400,00  €
66	4.000,00  €
67	4.000,00  €
68	4.000,00  €
69	3.000,00  €
70	2.600,00  €
71	2.000,00  €
72	2.700,00  €
73	2.200,00  €
74	4.000,00  €
75	3.300,00  €
76	6.000,00  €
77	6.600,00  €
78	2.200,00  €
79	6.600,00  €
80	4.000,00  €
81	2.600,00  €
82	8.000,00  €
83	2.000,00  €
84	3.000,00  €
85	2.000,00  €
86	2.000,00  €
87	2.000,00  €
88	6.000,00  €
89	2.000,00  €
90	1.800,00  €
91	1.800,00  €
92	1.800,00  €
93	3.000,00  €
94	2.000,00  €
95	3.600,00  €
96	2.200,00  €
97	2.700,00  €
98	4.800,00  €
99	5.600,00  €
100	2.000,00  €</cbc:Description>
         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
         <cac:MainCommodityClassification>
            <cbc:ItemClassificationCode listName="cpv">33696500</cbc:ItemClassificationCode>
         </cac:MainCommodityClassification>
         <cac:RealizedLocation>
            <cac:Address>
               <cbc:CountrySubentityCode listName="nuts">EL303</cbc:CountrySubentityCode>
               <cac:Country>
                  <cbc:IdentificationCode listName="country">GRC</cbc:IdentificationCode>
               </cac:Country>
            </cac:Address>
         </cac:RealizedLocation>
         <cac:PlannedPeriod>
            <cbc:DurationMeasure unitCode="YEAR">1</cbc:DurationMeasure>
         </cac:PlannedPeriod>
      </cac:ProcurementProject>
   </cac:ProcurementProjectLot>
   <cac:ProcurementProjectLot>
      <cbc:ID schemeName="Lot">LOT-0002</cbc:ID>
      <cac:TenderingTerms>
         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
         <cac:CallForTendersDocumentReference>
            <cbc:ID>Α/Α 378623</cbc:ID>
            <cbc:DocumentType>non-restricted-document</cbc:DocumentType>
            <cac:Attachment>
               <cac:ExternalReference>
                  <cbc:URI>https://nepps-search.eprocurement.gov.gr/actSearch/resources/search/378623</cbc:URI>
               </cac:ExternalReference>
            </cac:Attachment>
         </cac:CallForTendersDocumentReference>
         <cac:TendererQualificationRequest>
            <cac:SpecificTendererRequirement>
               <cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
            </cac:SpecificTendererRequirement>
         </cac:TendererQualificationRequest>
         <cac:TendererQualificationRequest>
            <cac:SpecificTendererRequirement>
               <cbc:TendererRequirementTypeCode listName="reserved-procurement">none</cbc:TendererRequirementTypeCode>
            </cac:SpecificTendererRequirement>
         </cac:TendererQualificationRequest>
         <cac:ContractExecutionRequirement>
            <cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
         </cac:ContractExecutionRequirement>
         <cac:ContractExecutionRequirement>
            <cbc:ExecutionRequirementCode listName="einvoicing">required</cbc:ExecutionRequirementCode>
         </cac:ContractExecutionRequirement>
         <cac:ContractExecutionRequirement>
            <cbc:ExecutionRequirementCode listName="ecatalog-submission">not-allowed</cbc:ExecutionRequirementCode>
         </cac:ContractExecutionRequirement>
         <cac:AwardingTerms>
            <cac:AwardingCriterion>
               <cbc:CalculationExpression languageID="ELL">ΚΡΙΤΗΡΙΟ ΚΑΤΑΚΥΡΩΣΗΣ ΕΙΝΑΙ Η ΧΑΜΗΛΟΤΕΡΗ ΤΙΜΗ</cbc:CalculationExpression>
               <cac:SubordinateAwardingCriterion>
                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
                  <cbc:Description languageID="ELL">ΚΡΙΤΗΡΙΟ ΚΑΤΑΚΥΡΩΣΗΣ ΕΙΝΑΙ Η ΧΑΜΗΛΟΤΕΡΗ ΤΙΜΗ</cbc:Description>
               </cac:SubordinateAwardingCriterion>
            </cac:AwardingCriterion>
         </cac:AwardingTerms>
         <cac:TenderRecipientParty>
            <cbc:EndpointID>https://portal.eprocurement.gov.gr/webcenter/portal/TestPortal</cbc:EndpointID>
         </cac:TenderRecipientParty>
         <cac:TenderValidityPeriod>
            <cbc:DurationMeasure unitCode="MONTH">12</cbc:DurationMeasure>
         </cac:TenderValidityPeriod>
         <cac:AppealTerms>
            <cac:AppealInformationParty>
               <cac:PartyIdentification>
                  <cbc:ID>ORG-0001</cbc:ID>
               </cac:PartyIdentification>
            </cac:AppealInformationParty>
            <cac:AppealReceiverParty>
               <cac:PartyIdentification>
                  <cbc:ID>ORG-0002</cbc:ID>
               </cac:PartyIdentification>
            </cac:AppealReceiverParty>
         </cac:AppealTerms>
         <cac:Language>
            <cbc:ID>ELL</cbc:ID>
         </cac:Language>
         <cac:PostAwardProcess>
            <cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
            <cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
         </cac:PostAwardProcess>
      </cac:TenderingTerms>
      <cac:TenderingProcess>
         <cbc:SubmissionMethodCode listName="esubmission">required</cbc:SubmissionMethodCode>
         <cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
         <cac:TenderSubmissionDeadlinePeriod>
            <cbc:EndDate>2025-09-26+03:00</cbc:EndDate>
            <cbc:EndTime>15:00:00+03:00</cbc:EndTime>
         </cac:TenderSubmissionDeadlinePeriod>
         <cac:OpenTenderEvent>
            <cbc:OccurrenceDate>2025-09-29+03:00</cbc:OccurrenceDate>
            <cbc:OccurrenceTime>10:00:00+03:00</cbc:OccurrenceTime>
         </cac:OpenTenderEvent>
         <cac:AuctionTerms>
            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
         </cac:AuctionTerms>
         <cac:ContractingSystem>
            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
         </cac:ContractingSystem>
         <cac:ContractingSystem>
            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
         </cac:ContractingSystem>
      </cac:TenderingProcess>
      <cac:ProcurementProject>
         <cbc:Name languageID="ELL">ΤΜΗΜΑΤΑ ΑΠΟ 101 - 200</cbc:Name>
         <cbc:Description languageID="ELL">ΤΜΗΜΑ - ΠΕΡΙΓΡΑΦΗ 
101	RABBIT ANTI HUMAN CEA
102	MOUSE ANTI HUMAN CHROMOGRANIN A
103	MOUSE ANTI HUMAN CLAUDIN-1
104	MOUSE ANTI HUMAN CMV
105	MOUSE ANTI HUMAN C-MYC
106	MOUSE ANTI HUMAN COLLAGEN IV
107	MOUSE ANTI HUMAN CYCLIN D1
108	MOUSE ANTI HUMAN BRACHYURY
109	MOUSE ANTI HUMAN OTX2
110	MOUSE ANTI HUMAN CYTOKERATIN 5/6 (D5/16B4)
111	MOUSE ANTI HUMAN CYTOKERATIN 7 (OV-TL 12/30)
112	MOUSE ANTI HUMAN CYTOKERATIN 8&amp;18
113	MOUSE ANTI HUMAN IDH2 R172K
114	MOUSE ANTI HUMAN CYTOKERATIN 17
115	MOUSE ANTI HUMAN CYTOKERATIN 19
116	MOUSE ANTI HUMAN CYTOKERATIN 20 (Ks20.8)
117	MOUSE ANTI HUMAN CYTOKERATIN HIGH  MOLECULAR WEIGHT 34βE12
118	MOUSE ANTI HUMAN DAXX
119	MOUSE ANTI HUMAN PODOPLANIN (D2-40)
120	MOUSE ANTI HUMAN DESMIN (D33)
121	MOUSE ANTI HUMAN DOG-1
122	MOUSE ANTI HUMAN E-CADHERIN
123	MOUSE ANTI HUMAN EMA (E29)
124	MOUSE ANTI HUMAN Ep-CAM
125	MOUSE ANTI HUMAN EPITHELIAL ANTIGEN  (Ber-EP4)
126	MOUSE ANTI HUMAN EPSTEIN- BARR VIRUS LMP (CS.1-4)
127	MOUSE ANTI HUMAN EPITHELIAL RELATED ANTIGEN ( MOC-31 )
128	MOUSE ANTI HUMAN ERG
129	MOUSE ANTI HUMAN ESTROGEN RECEPTOR
130	RABBIT ANTI HUMAN IGA,IGG,IGM,K,L/FITC
131	MOUSE ANTI HUMAN FSH
132	MOUSE ANTI HUMAN FLi-1
133	MOUSE ANTI HUMAN FOXP1
134	MOUSE ANTI HUMAN FUBP1
135	MOUSE ANTI HUMAN FXIIIA
136	MOUSE ANTI HUMAN GALECTIN-3
137	RABBIT ANTI HUMAN GASTRIN
138	MOUSE ANTI HUMAN GATA-3
139	MOUSE ANTI HUMAN C-myb
140	MOUSE ANTI HUMAN GFAP
141	MOUSE ANTI HUMAN GLUCOSE TRANSPORTER TYPE 1
142	MOUSE ANTI HUMAN GLYCOPHORIN C
143	MOUSE ANTI HUMAN GLYPICAN-3
144	MOUSE ANTI HUMAN GLUTAMINE SYNTHETASE
145	MOUSE ANTI HUMAN GRANZYME B
146	MOUSE ANTI HUMAN GROSS CYSTIC DISEASE FLUID PROTEIN -15
147	MOUSE ANTI HUMAN GROWTH HORMONE
148	MOUSE ANTI HUMAN ANTI-TRIMETHYL-HISTONE H3 (Lys27)
149	MOUSE ANTI HUMAN HCG beta
150	RABBIT ANTI HUMAN HELICOBACTER PYLORI
151	MOUSE ANTI HUMAN  AQUAPORIN-4
152	RABBIT ANTI HUMAN HEPATITIS B VIRUS CORE ANTIGEN
153	MOUSE ANTI HUMAN HEPATITIS B VIRUS SURFACE ANTIGEN
154	MOUSE ANTI HUMAN HEPATOCYTE (OCH1E5)
155	MOUSE ANTI HUMAN HER-2 /neu (EP3)
156	MOUSE ANTI HUMAN HHV-8 (13B10)
157	MOUSE ANTI HUMAN ANTI-HISTONE H3 K27M
158	MOUSE ANTI HUMAN HOXB13
159	MOUSE ANTI HUMAN HPV
160	MOUSE ANTI HUMAN HPV16
161	MOUSE ANTI HUMAN HPV18
162	RABBIT ANTI HUMAN HERPES SIMPLEX VIRUS I
163	RABBIT ANTI HUMAN HERPES SIMPLEX VIRUS II
164	MOUSE ANTI HUMAN IDH1 (H-09)
165	MOUSE ANTI HUMAN IDH 1/2 MUTANT (R132/172)
166	MOUSE ANTI HUMAN IGA
167	RABBIT ANTI HUMAN IGD
168	MOUSE ANTI HUMAN IGG
169	MOUSE ANTI HUMAN IGG4
170	MOUSE ANTI HUMAN IGM
171	MOUSE ANTI HUMAN INHIBIN alpha
172	MOUSE ANTI HUMAN INI-1
173	MOUSE ANTI HUMAN C11B2/CYP11B2
174	MOUSE ANTI HUMAN Ki-67 ANTIGEN (MIB-1)
175	RABBIT ANTI HUMAN KAPPA LIGHT CHAINS
176	MOUSE ANTI HUMAN KIDNEY SPECIFIC CADHERIN
177	RABBIT ANTI HUMAN LAMBDA LIGHT CHAINS
178	MOUSE ANTI HUMAN NF-KBp65
179	MOUSE ANTI HUMAN LANGERIN
180	MOUSE ANTI HUMAN LCA
181	MOUSE ANTI HUMAN LEUKAEMIA HAIRY CELL
182	MOUSE ANTI HUMAN LH
183	MOUSE ANTI HUMAN LH beta
184	MOUSE ANTI HUMAN MAST CELL TRYPTASE
185	MOUSE ANTI HUMAN MDM2
186	MOUSE ANTI HUMAN MELAN-A (A103)
187	MOUSE ANTI HUMAN MELANOSOME (HMB-45)
188	MOUSE ANTI HUMAN MESOTHELIAL CELL (HBME-1)
189	MOUSE ANTI HUMAN MiTF
190	MOUSE ANTI HUMAN MUTS PROTEIN HOMOLOG 2
191	MOUSE ANTI HUMAN MUTS PROTEIN HOMOLOG 6
192	MOUSE ANTI HUMAN MUTL PROTEIN HOMOLOG 1
193	MOUSE ANTI HUMAN MUC1
194	MOUSE ANTI HUMAN MUC2
195	MOUSE ANTI HUMAN MUC4
196	MOUSE ANTI HUMAN MUC5AC
197	MOUSE ANTI HUMAN MUC6
198	MOUSE ANTI HUMAN MUM1 PROTEIN (MUM1p)
199	MOUSE ANTI HUMAN MYCOBACTERIUM TUBERCULOSIS
200	MOUSE ANTI HUMAN MYOD1 5.8A
 ΣΥΝΟΛΟ ΠΡΟ Φ.Π.Α. 
101	1.600,00  €
102	7.200,00  €
103	2.200,00  €
104	8.000,00  €
105	7.200,00  €
106	1.600,00  €
107	6.600,00  €
108	2.400,00  €
109	4.800,00  €
110	8.000,00  €
111	6.000,00  €
112	6.000,00  €
113	6.400,00  €
114	6.000,00  €
115	6.000,00  €
116	12.000,00 €
117	6.000,00  €
118	6.000,00  €
119	6.600,00  €
120	2.700,00  €
121	2.200,00  €
122	4.400,00  €
123	4.800,00  €
124	7.200,00  €
125	1.800,00  €
126	2.700,00  €
127	3.300,00  €
128	3.600,00  €
129	4.800,00  €
130	1.600,00  €
131	2.000,00  €
132	3.000,00  €
133	2.400,00  €
134	7.200,00  €
135	2.200,00  €
136	3.000,00  €
137	1.800,00  €
138	6.600,00  €
139	4.800,00  €
140	4.000,00  €
141	2.400,00  €
142	1.800,00  €
143	4.000,00  €
144	2.800,00  €
145	2.000,00  €
146	2.000,00  €
147	1.800,00  €
148	8.400,00  €
149	1.400,00  €
150	6.000,00  €
151	2.400,00  €
152	700,00  €
153	700,00  €
154	2.700,00  €
155	4.800,00  €
156	6.000,00  €
157	8.400,00  €
158	4.800,00  €
159	6.000,00  €
160	2.000,00  €
161	7.200,00  €
162	1.600,00  €
163	1.600,00  €
164	11.200,00  €
165	11.200,00  €
166	1.200,00  €
167	1.600,00  €
168	1.200,00  €
169	2.200,00  €
170	1.200,00  €
171	3.300,00  €
172	3.300,00  €
173	4.800,00  €
174	9.600,00  €
175	600,00  €
176	2.200,00  €
177	600,00  €
178	3.600,00  €
179	2.000,00  €
180	2.700,00  €
181	1.600,00  €
182	2.000,00  €
183	4.800,00  €
184	2.000,00  €
185	3.000,00  €
186	8.000,00  €
187	6.000,00  €
188	3.000,00  €
189	2.000,00  €
190	7.200,00  €
191	7.200,00  €
192	7.200,00  €
193	1.800,00  €
194	1.800,00  €
195	1.800,00  €
196	1.800,00  €
197	1.800,00  €
198	4.400,00  €
199	800,00  €
200	2.000,00  €</cbc:Description>
         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
         <cac:MainCommodityClassification>
            <cbc:ItemClassificationCode listName="cpv">33696500</cbc:ItemClassificationCode>
         </cac:MainCommodityClassification>
         <cac:RealizedLocation>
            <cac:Address>
               <cbc:CountrySubentityCode listName="nuts">EL303</cbc:CountrySubentityCode>
               <cac:Country>
                  <cbc:IdentificationCode listName="country">GRC</cbc:IdentificationCode>
               </cac:Country>
            </cac:Address>
         </cac:RealizedLocation>
         <cac:PlannedPeriod>
            <cbc:DurationMeasure unitCode="YEAR">1</cbc:DurationMeasure>
         </cac:PlannedPeriod>
      </cac:ProcurementProject>
   </cac:ProcurementProjectLot>
   <cac:ProcurementProjectLot>
      <cbc:ID schemeName="Lot">LOT-0003</cbc:ID>
      <cac:TenderingTerms>
         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
         <cac:CallForTendersDocumentReference>
            <cbc:ID>Α/Α 378623</cbc:ID>
            <cbc:DocumentType>non-restricted-document</cbc:DocumentType>
            <cac:Attachment>
               <cac:ExternalReference>
                  <cbc:URI>https://nepps-search.eprocurement.gov.gr/actSearch/resources/search/378623</cbc:URI>
               </cac:ExternalReference>
            </cac:Attachment>
         </cac:CallForTendersDocumentReference>
         <cac:TendererQualificationRequest>
            <cac:SpecificTendererRequirement>
               <cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
            </cac:SpecificTendererRequirement>
         </cac:TendererQualificationRequest>
         <cac:TendererQualificationRequest>
            <cac:SpecificTendererRequirement>
               <cbc:TendererRequirementTypeCode listName="reserved-procurement">none</cbc:TendererRequirementTypeCode>
            </cac:SpecificTendererRequirement>
         </cac:TendererQualificationRequest>
         <cac:ContractExecutionRequirement>
            <cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
         </cac:ContractExecutionRequirement>
         <cac:ContractExecutionRequirement>
            <cbc:ExecutionRequirementCode listName="einvoicing">required</cbc:ExecutionRequirementCode>
         </cac:ContractExecutionRequirement>
         <cac:ContractExecutionRequirement>
            <cbc:ExecutionRequirementCode listName="ecatalog-submission">not-allowed</cbc:ExecutionRequirementCode>
         </cac:ContractExecutionRequirement>
         <cac:AwardingTerms>
            <cac:AwardingCriterion>
               <cbc:CalculationExpression languageID="ELL">ΚΡΙΤΗΡΙΟ ΚΑΤΑΚΥΡΩΣΗΣ ΕΙΝΑΙ Η ΧΑΜΗΛΟΤΕΡΗ ΤΙΜΗ</cbc:CalculationExpression>
               <cac:SubordinateAwardingCriterion>
                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
                  <cbc:Description languageID="ELL">ΚΡΙΤΗΡΙΟ ΚΑΤΑΚΥΡΩΣΗΣ ΕΙΝΑΙ Η ΧΑΜΗΛΟΤΕΡΗ ΤΙΜΗ</cbc:Description>
               </cac:SubordinateAwardingCriterion>
            </cac:AwardingCriterion>
         </cac:AwardingTerms>
         <cac:TenderRecipientParty>
            <cbc:EndpointID>https://portal.eprocurement.gov.gr/webcenter/portal/TestPortal</cbc:EndpointID>
         </cac:TenderRecipientParty>
         <cac:TenderValidityPeriod>
            <cbc:DurationMeasure unitCode="MONTH">12</cbc:DurationMeasure>
         </cac:TenderValidityPeriod>
         <cac:AppealTerms>
            <cac:AppealInformationParty>
               <cac:PartyIdentification>
                  <cbc:ID>ORG-0001</cbc:ID>
               </cac:PartyIdentification>
            </cac:AppealInformationParty>
            <cac:AppealReceiverParty>
               <cac:PartyIdentification>
                  <cbc:ID>ORG-0002</cbc:ID>
               </cac:PartyIdentification>
            </cac:AppealReceiverParty>
         </cac:AppealTerms>
         <cac:Language>
            <cbc:ID>ELL</cbc:ID>
         </cac:Language>
         <cac:PostAwardProcess>
            <cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
            <cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
         </cac:PostAwardProcess>
      </cac:TenderingTerms>
      <cac:TenderingProcess>
         <cbc:SubmissionMethodCode listName="esubmission">required</cbc:SubmissionMethodCode>
         <cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
         <cac:TenderSubmissionDeadlinePeriod>
            <cbc:EndDate>2025-09-26+03:00</cbc:EndDate>
            <cbc:EndTime>15:00:00+03:00</cbc:EndTime>
         </cac:TenderSubmissionDeadlinePeriod>
         <cac:OpenTenderEvent>
            <cbc:OccurrenceDate>2025-09-29+03:00</cbc:OccurrenceDate>
            <cbc:OccurrenceTime>10:00:00+03:00</cbc:OccurrenceTime>
         </cac:OpenTenderEvent>
         <cac:AuctionTerms>
            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
         </cac:AuctionTerms>
         <cac:ContractingSystem>
            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
         </cac:ContractingSystem>
         <cac:ContractingSystem>
            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
         </cac:ContractingSystem>
      </cac:TenderingProcess>
      <cac:ProcurementProject>
         <cbc:Name languageID="ELL">ΤΜΗΜΑΤΑ ΑΠΟ 201 - 300</cbc:Name>
         <cbc:Description languageID="ELL">ΤΜΗΜΑ - ΠΕΡΙΓΡΑΦΗ 
201	MOUSE ANTI HUMAN MYELIN BASIC PROTEIN
202	RABBIT ANTI HUMAN MYELOPEROXIDASE
203	MOUSE ANTI HUMAN RET
204	MOUSE ANTI HUMAN NESTIN
205	MOUSE ANTI HUMAN NEUN
206	MOUSE ANTI HUMAN NEUROFILAMENT (2F11)
207	MOUSE ANTI HUMAN NSE
208	MOUSE  ANTI HUMAN NUT
209	MOUSE ANTI HUMAN OCT-2
210	MOUSE ANTI HUMAN P16
211	MOUSE ANTI HUMAN P27 /kip1
212	MOUSE ANTI HUMAN P40
213	MOUSE ANTI HUMAN P53 (DO-7)
214	MOUSE ANTI HUMAN P63
215	MOUSE ANTI HUMAN P501S
216	MOUSE ANTI HUMAN AMACR
217	MOUSE ANTI HUMAN TCRdelta
218	MOUSE ANTI HUMAN PAX-2
219	MOUSE ANTI HUMAN B-CELL-SPECIFIC ACTIVATOR PROTEIN (PAX-5)
220	MOUSE ANTI HUMAN PAX-8
221	MOUSE ANTI HUMAN PD-1
222	MOUSE ANTI HUMAN PDX1
223	MOUSE ANTI HUMAN PERFORIN
224	MOUSE ANTI HUMAN PHH3
225	MOUSE ANTI HUMAN PLACENTAL ALKALINE  PHOSPHATASE
226	MOUSE ANTI HUMAN POSTMEIOTIC SEGRAGATION INCREASED 2
227	MOUSE ANTI HUMAN PROGESTERONE RECEPTOR
228	MOUSE ANTI HUMAN PROSTATE SPECIFIC ANTIGEN (ER-PR8)
229	MOUSE ANTI HUMAN PROSTATIC ACID PHOSPHATASE (PASE/4LJ)
230	MOUSE ANTI HUMAN  pVHL
231	MOUSE ANTI HUMAN RENAL CELL CARCINOMA
232	MOUSE ANTI HUMAN S-100
233	MOUSE ANTI HUMAN SEROTONIN
234	MOUSE ANTI HUMAN SMAD4/DPC4
235	MOUSE ANTI HUMAN SMOOTH MUSCLE ACTIN
236	MOUSE ANTI HUMAN MAX
237	MOUSE ANTI HUMAN SMOOTHELIN
238	MOUSE ANTI HUMAN SOMATOSTATIN
239	MOUSE ANTI HUMAN SOX-10
240	MOUSE ANTI HUMAN SOX-11
241	MOUSE ANTI HUMAN STEROIDOGENIC FACTOR-1 (SF-1)
242	MOUSE ANTI HUMAN SYNAPTOPHYSIN
243	MOUSE ANTI HUMAN T-BET
244	MOUSE ANTI HUMAN TCL-1
245	MOUSE ANTI HUMAN TCRαlpha
246	MOUSE ANTI HUMAN TDT (EP266)
247	MOUSE ANTI HUMAN TFE3
248	MOUSE ANTI HUMAN THROMBOMODULIN
249	MOUSE ANTI HUMAN THYROGLOBULIN
250	MOUSE ANTI HUMAN TIA-1
251	MOUSE ANTI HUMAN MYELIN OLIGODENDROCYTE GLYCOPROTEIN
252	MOUSE ANTI HUMAN TSH
253	MOUSE ANTI HUMAN TTF-1 (8G7G3/1)
254	MOUSE ANTI HUMAN TYROSINASE
255	MOUSE ANTI HUMAN UROPLAKIN II
256	MOUSE ANTI HUMAN VEGF
257	MOUSE ANTI HUMAN VIMENTIN (V9)
258	MOUSE ANTI HUMAN VIP
259	MOUSE ANTI HUMAN VON WILLEBRAND  FACTOR
260	MOUSE ANTI HUMAN TRAcP
261	MOUSE ANTI HUMAN ZAP-70 (2F3.2)
262	MOUSE ANTI HUMAN ARGINASE
263	MOUSE ANTI HUMAN BAP1
264	MOUSE ANTI HUMAN EZH2
265	MOUSE ANTI HUMAN BRG1
266	MOUSE ANTI HUMAN AIP
267	MOUSE ANTI HUMAN VILLIN
268	MOUSE ANTI HUMAN SARS-COV-2
269	MOUSE ANTI HUMAN CD103
270	RABBIT ANTI HUMAN CAMTA
271	MOUSE ANTI HUMAN MTAP
272	MOUSE ANTI HUMAN CHYMOTRYPSIN
273	MOUSE ANTI HUMAN anti-MASH1/A chaete-scute hololog1
274	MOUSE ANTI HUMAN CLUSTERIN
275	MOUSE ANTI HUMAN CDK4
276	MOUSE ANTI HUMAN SOX-2
277	MOUSE ANTI HUMAN PLAG1
278	MOUSE ANTI HUMAN FOXG1
279	MOUSE ANTI HUMAN FUMARATE HYDRATASE
280	MOUSE ANTI HUMAN HNF-4alpha
281	MOUSE ANTI HUMAN CYTOKERATIN 14
282	MOUSE ANTI HUMAN ANTI-HISTONE H3.3 G34V
283	MOUSE ANTI HUMAN INSMI
284	MOUSE ANTI HUMAN LEF-1
285	MOUSE ANTI HUMAN LIN28A
286	MOUSE ANTI HUMAN L1CAM
287	MOUSE ANTI HUMAN MAMMAGLOBIN
288	MOUSE ANTI HUMAN MCPyV
289	MOUSE ANTI HUMAN CALDESMON
290	MOUSE ANTI HUMAN GAB1
291	MOUSE ANTI HUMAN MENIN
292	MOUSE ANTI HUMAN NESP-55
293	MOUSE ANTI HUMAN NKX2.2
294	MOUSE ANTI HUMAN OLIG2
295	MOUSE ANTI HUMAN OTP
296	MOUSE ANTI HUMAN WAF1/cip1
297	MOUSE ANTI HUMAN PAX-6
298	MOUSE ANTI HUMAN PIT1
299	MOUSE ANTI HUMAN PLA2R
300	RABBIT ANTI HUMAN PANCREATIC POLYPEPTIDE
 ΣΥΝΟΛΟ ΠΡΟ Φ.Π.Α. 
201	1.400,00  €
202	1.600,00  €
203	2.400,00  €
204	2.200,00  €
205	2.200,00  €
206	1.800,00  €
207	2.000,00  €
208	6.000,00  €
209	2.200,00  €
210	5.200,00  €
211	2.000,00  €
212	7.800,00  €
213	8.000,00  €
214	6.600,00  €
215	2.200,00  €
216	6.600,00  €
217	2.400,00  €
218	2.400,00  €
219	2.200,00  €
220	7.800,00  €
221	2.000,00  €
222	4.800,00  €
223	2.200,00  €
224	2.000,00  €
225	1.600,00  €
226	7.200,00  €
227	5.200,00  €
228	1.400,00  €
229	1.400,00  €
230	2.400,00  €
231	4.000,00  €
232	6.000,00  €
233	7.800,00  €
234	2.400,00  €
235	2.700,00  €
236	2.400,00  €
237	2.200,00  €
238	2.000,00  €
239	4.800,00  €
240	2.200,00  €
241	4.800,00  €
242	4.800,00  €
243	2.200,00  €
244	2.200,00  €
245	2.400,00  €
246	4.800,00  €
247	2.400,00  €
248	2.000,00  €
249	1.800,00  €
250	2.200,00  €
251	2.400,00  €
252	2.000,00  €
253	7.200,00  €
254	2.000,00  €
255	4.800,00  €
256	3.200,00  €
257	3.200,00  €
258	2.400,00  €
259	1.400,00  €
260	1.600,00  €
261	1.600,00  €
262	5.100,00  €
263	6.400,00  €
264	2.800,00  €
265	4.800,00  €
266	2.400,00  €
267	1.100,00  €
268	3.600,00  €
269	2.400,00  €
270	2.400,00  €
271	3.400,00  €
272	2.400,00  €
273	6.400,00  €
274	2.200,00  €
275	3.200,00  €
276	3.200,00  €
277	3.200,00  €
278	4.800,00  €
279	2.400,00  €
280	3.600,00  €
281	5.500,00  €
282	11.200,00  €
283	6.000,00  €
284	2.400,00  €
285	2.400,00  €
286	2.400,00  €
287	3.400,00  €
288	2.400,00  €
289	2.200,00  €
290	2.600,00  €
291	4.800,00  €
292	2.400,00  €
293	2.200,00  €
294	4.800,00  €
295	2.400,00  €
296	2.800,00  €
297	3.200,00  €
298	7.200,00  €
299	2.400,00  €
300	2.400,00  €
</cbc:Description>
         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
         <cac:MainCommodityClassification>
            <cbc:ItemClassificationCode listName="cpv">33696500</cbc:ItemClassificationCode>
         </cac:MainCommodityClassification>
         <cac:RealizedLocation>
            <cac:Address>
               <cbc:CountrySubentityCode listName="nuts">EL303</cbc:CountrySubentityCode>
               <cac:Country>
                  <cbc:IdentificationCode listName="country">GRC</cbc:IdentificationCode>
               </cac:Country>
            </cac:Address>
         </cac:RealizedLocation>
         <cac:PlannedPeriod>
            <cbc:DurationMeasure unitCode="YEAR">1</cbc:DurationMeasure>
         </cac:PlannedPeriod>
      </cac:ProcurementProject>
   </cac:ProcurementProjectLot>
   <cac:ProcurementProjectLot>
      <cbc:ID schemeName="Lot">LOT-0004</cbc:ID>
      <cac:TenderingTerms>
         <cbc:FundingProgramCode listName="eu-funded">no-eu-funds</cbc:FundingProgramCode>
         <cac:CallForTendersDocumentReference>
            <cbc:ID>Α/Α 378623</cbc:ID>
            <cbc:DocumentType>non-restricted-document</cbc:DocumentType>
            <cac:Attachment>
               <cac:ExternalReference>
                  <cbc:URI>https://nepps-search.eprocurement.gov.gr/actSearch/resources/search/378623</cbc:URI>
               </cac:ExternalReference>
            </cac:Attachment>
         </cac:CallForTendersDocumentReference>
         <cac:TendererQualificationRequest>
            <cac:SpecificTendererRequirement>
               <cbc:TendererRequirementTypeCode listName="selection-criteria-source">epo-procurement-document</cbc:TendererRequirementTypeCode>
            </cac:SpecificTendererRequirement>
         </cac:TendererQualificationRequest>
         <cac:TendererQualificationRequest>
            <cac:SpecificTendererRequirement>
               <cbc:TendererRequirementTypeCode listName="reserved-procurement">none</cbc:TendererRequirementTypeCode>
            </cac:SpecificTendererRequirement>
         </cac:TendererQualificationRequest>
         <cac:ContractExecutionRequirement>
            <cbc:ExecutionRequirementCode listName="reserved-execution">not-known</cbc:ExecutionRequirementCode>
         </cac:ContractExecutionRequirement>
         <cac:ContractExecutionRequirement>
            <cbc:ExecutionRequirementCode listName="einvoicing">required</cbc:ExecutionRequirementCode>
         </cac:ContractExecutionRequirement>
         <cac:ContractExecutionRequirement>
            <cbc:ExecutionRequirementCode listName="ecatalog-submission">not-allowed</cbc:ExecutionRequirementCode>
         </cac:ContractExecutionRequirement>
         <cac:AwardingTerms>
            <cac:AwardingCriterion>
               <cbc:CalculationExpression languageID="ELL">ΚΡΙΤΗΡΙΟ ΚΑΤΑΚΥΡΩΣΗΣ ΕΙΝΑΙ Η ΧΑΜΗΛΟΤΕΡΗ ΤΙΜΗ</cbc:CalculationExpression>
               <cac:SubordinateAwardingCriterion>
                  <cbc:AwardingCriterionTypeCode listName="award-criterion-type">price</cbc:AwardingCriterionTypeCode>
                  <cbc:Description languageID="ELL">ΚΡΙΤΗΡΙΟ ΚΑΤΑΚΥΡΩΣΗΣ ΕΙΝΑΙ Η ΧΑΜΗΛΟΤΕΡΗ ΤΙΜΗ</cbc:Description>
               </cac:SubordinateAwardingCriterion>
            </cac:AwardingCriterion>
         </cac:AwardingTerms>
         <cac:TenderRecipientParty>
            <cbc:EndpointID>https://portal.eprocurement.gov.gr/webcenter/portal/TestPortal</cbc:EndpointID>
         </cac:TenderRecipientParty>
         <cac:TenderValidityPeriod>
            <cbc:DurationMeasure unitCode="MONTH">12</cbc:DurationMeasure>
         </cac:TenderValidityPeriod>
         <cac:AppealTerms>
            <cac:AppealInformationParty>
               <cac:PartyIdentification>
                  <cbc:ID>ORG-0001</cbc:ID>
               </cac:PartyIdentification>
            </cac:AppealInformationParty>
            <cac:AppealReceiverParty>
               <cac:PartyIdentification>
                  <cbc:ID>ORG-0002</cbc:ID>
               </cac:PartyIdentification>
            </cac:AppealReceiverParty>
         </cac:AppealTerms>
         <cac:Language>
            <cbc:ID>ELL</cbc:ID>
         </cac:Language>
         <cac:PostAwardProcess>
            <cbc:ElectronicOrderUsageIndicator>false</cbc:ElectronicOrderUsageIndicator>
            <cbc:ElectronicPaymentUsageIndicator>true</cbc:ElectronicPaymentUsageIndicator>
         </cac:PostAwardProcess>
      </cac:TenderingTerms>
      <cac:TenderingProcess>
         <cbc:SubmissionMethodCode listName="esubmission">required</cbc:SubmissionMethodCode>
         <cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
         <cac:TenderSubmissionDeadlinePeriod>
            <cbc:EndDate>2025-09-26+03:00</cbc:EndDate>
            <cbc:EndTime>15:00:00+03:00</cbc:EndTime>
         </cac:TenderSubmissionDeadlinePeriod>
         <cac:OpenTenderEvent>
            <cbc:OccurrenceDate>2025-09-29+03:00</cbc:OccurrenceDate>
            <cbc:OccurrenceTime>10:00:00+03:00</cbc:OccurrenceTime>
         </cac:OpenTenderEvent>
         <cac:AuctionTerms>
            <cbc:AuctionConstraintIndicator>false</cbc:AuctionConstraintIndicator>
         </cac:AuctionTerms>
         <cac:ContractingSystem>
            <cbc:ContractingSystemTypeCode listName="framework-agreement">none</cbc:ContractingSystemTypeCode>
         </cac:ContractingSystem>
         <cac:ContractingSystem>
            <cbc:ContractingSystemTypeCode listName="dps-usage">none</cbc:ContractingSystemTypeCode>
         </cac:ContractingSystem>
      </cac:TenderingProcess>
      <cac:ProcurementProject>
         <cbc:Name languageID="ELL">ΤΜΗΜΑΤΑ ΑΠΟ 301 - 387 </cbc:Name>
         <cbc:Description languageID="ELL">ΤΜΗΜΑ - ΠΕΡΙΓΡΑΦΗ 
301	MOUSE ANTI HUMAN PTEN
302	MOUSE ANTI HUMAN PHOX2B
303	MOUSE ANTI HUMAN RETINOBLASTOMA
304	MOUSE ANTI HUMAN S-100  PLACENTAL
305	MOUSE  ANTI HUMAN SATB2
306	MOUSE ANTI HUMAN SDHA
307	MOUSE ANTI HUMAN SDHB
308	MOUSE ANTI HUMAN SDHD
309	MOUSE ANTI HUMAN BCOR
310	MOUSE ANTI HUMAN SOMATOSTATIN RECEPTOR 2
311	MOUSE ANTI HUMAN SOMATOSTATIN RECEPTOR 5
312	MOUSE ANTI HUMAN STAT-6
313	MOUSE ANTI HUMAN ALPHA-SUBUNIT
314	RABBIT ANTI HUMAN CD117
315	MOUSE ANTI HUMAN SMARCA2/BRM
316	MOUSE ANTI HUMAN ANTI-MITOCHONDRIA
317	MOUSE ANTI HUMAN TPIT
318	MOUSE ANTI HUMAN TRANSTHYRETIN
319	MOUSE ANTI HUMAN TRPS1
320	MOUSE ANTI HUMAN TYROSINE HYDROXYLASE
321	MOUSE ANTI HUMAN PARAFIBROMIN
322	MOUSE ANTI HUMAN YAP1
323	MOUSE ANTI HUMAN CXCL13
324	MOUSE ANTI HUMAN CYTOKERATIN 13
325	MOUSE ANTI HUMAN STAT-3 PHOSPHO
326	MOUSE ANTI HUMAN STAT-3
327	MOUSE ANTI HUMAN MAL
328	MOUSE ANTI HUMAN PRKARIA B
329	MOUSE ANTI HUMAN PRAME
330	MOUSE ANTI HUMAN KCNJ5
331	MOUSE ANTI HUMAN CYTOCHROME P450
332	MOUSE ANTI HUMAN IGF1
333	RABBIT ANTI HUMAN KAPPA LIGHT CHAINS/FITC
334	RABBIT ANTI HUMAN LAMBDA LIGHT CHAINS/FITC
335	POLYCLONAL RABBIT ANTI HUMAN C4D/FITC
336	POLYCLONAL RABBIT ANTI-HUMAN ALBUMIN/FITC
337	POLYCLONAL RABBIT ANTIHUMAN C3C/FITC
338	POLYCLONAL RABBIT ANTIHUMAN C4C/FITC
339	POLYCLONAL RABBIT ANTI-HUMAN  FIBRINOGEN/FITC
340	POLYCLONAL RABBIT ANTI-HUMAN IGA/FITC
341	POLYCLONAL RABBIT ANTI-HUMAN IGG/FITC
342	POLYCLONAL RABBIT ANTI-HUMAN IGΜ/FITC
343	MONOCLONAL MOUSE ANTI-HUMAN BRAF V600E (VE1)
344	MONOCLONAL MOUSE ANTI-HUMAN ALK D5F3
345	HERCEPTEST KIT FOR AUTOMATED PLATFORMS
346	PD-L1 IHC 22C3 KIT FOR AUTOMATED PLATFORMS
347	ANTIBODY  DILUENT
348	ANTIBODY DILUENT (TBST PH 7.6 WITH BSA AND SODIUM AZIDE)
349	TARGET RETRIEVAL SOLUTION CONCENTRATED  S1699
350	TARGET RETRIEVAL SOLUTION CONCENTRATED TRIS-EDTA PH 8.0
351	TARGET RETRIEVAL SOLUTION CONCENTRATED TAE PH 8.3
352	TARGET RETRIEVAL SOLUTION LOW PH 6.1
353	TARGET RETRIEVAL SOLUTION HIGH PH 9.9
354	IMMUNO DNA WASHER (20X)
355	IMMUNO DNA RETRIEVER CITRATE CONCENTRATED PH 6.1  FOR ISH , CISH, FISH
356	IMMUNO DNA RETRIEVER EDTA CONCENTRATED PH 9.5 FOR ISH, CISH, FISH
357	HEMATOXYLIN IMMUNOHISTOCHEMISTRY FOR AUTOSTAINER INSTRUMENTS
358	DUET PRESS DOUBLE STAINING HRP/AP POLYMER
359	POLYDETECTOR ALKALINE PHOSPHATASE KIT FOR MOUSE AND RABBIT
360	RABBIT FLUORODETECTOR FITC WITH FLUOROMOUNT AND DAPI
361	LIQUID DAB+
362	WASH SOLUTION X10
363	DEWAX SOLUTION
364	EPITOPE RETRIEVAL 1 SOLUTION, PH 6
365	EPITOPE RETRIEVAL 2 SOLUTION, PH 9
366	ENZYME PRETREATMENT KIT
367	ANTI-FLUORESCEIN AB RTU
368	ASPIRATING PROBE CLEANING KIT
369	REACTION BUFFER CONCENTRATE 10X
370	EZ PREP SOLUTION CONCENTRATE 10X
371	ULTRA CELL CONDITIONING 1
372	ULTRA CELL CONDITIONING 2
373	ULTRA LIQUID COVERSLIP SOLUTION
374	SSC SOLUTION 10X
375	HEMATOXYLIN (≤48%)
376	BLUING REAGENT
377	IHC AMPLIFICATION KIT
378	ALKALINE PHOSPHATASE RED DETECTION KIT
379	ISH DETECTION KIT
380	PROTEASE 1
381	PROTEASE 2
382	PROTEASE 3
383	ISH PROTEASE 3
384	RED COUNTERSTAIN II
385	ISH EBER RNA PROBE
386	ISH KAPPA mRNA PROBE
387	ISH LAMBDA mRNA PROBE
 ΣΥΝΟΛΟ ΠΡΟ Φ.Π.Α. 
301	3.600,00  €
302	1.100,00  €
303	5.200,00  €
304	3.000,00  €
305	6.400,00  €
306	2.400,00  €
307	4.800,00  €
308	2.400,00  €
309	2.600,00  €
310	4.800,00  €
311	4.800,00  €
312	3.400,00  €
313	4.800,00  €
314	6.000,00  €
315	4.800,00  €
316	3.400,00  €
317	7.200,00  €
318	2.400,00  €
319	6.400,00  €
320	2.400,00  €
321	3.200,00  €
322	9.600,00  €
323	2.400,00  €
324	2.400,00  €
325	2.400,00  €
326	2.400,00  €
327	2.400,00  €
328	2.400,00  €
329	3.400,00  €
330	4.800,00  €
331	4.800,00  €
332	2.400,00  €
333	2.400,00  €
334	2.400,00  €
335	2.400,00  €
336	2.400,00  €
337	3.600,00  €
338	3.600,00  €
339	3.600,00  €
340	3.600,00  €
341	3.600,00  €
342	3.600,00  €
343	23.850,00  €
344	9.540,00  €
345	38.400,00  €
346	52.000,00  €
347	80.000,00  €
348	50.000,00  €
349	72.000,00  €
350	32.000,00  €
351	32.000,00  €
352	40.000,00  €
353	120.000,00  €
354	24.000,00  €
355	64.000,00  €
356	64.000,00  €
357	80.000,00  €
358	12.000,00  €
359	25.200,00  €
360	18.000,00  €
361	3.600,00  €
362	10.650,00  €
363	7.500,00  €
364	15.300,00  €
365	8.000,00  €
366	400,00  €
367	950,00  €
368	422,00  €
369	3.750,00  €
370	4.460,00  €
371	3.345,00  €
372	2.230,00  €
373	4.000,00  €
374	2.230,00  €
375	1.500,00  €
376	1.500,00  €
377	1.620,00  €
378	1.590,00  €
379	3.180,00  €
380	149,00  €
381	149,00  €
382	298,00  €
383	745,00  €
384	1.550,00  €
385	18.179,00  €
386	1.590,00  €
387	1.590,00  €</cbc:Description>
         <cbc:ProcurementTypeCode listName="contract-nature">supplies</cbc:ProcurementTypeCode>
         <cac:MainCommodityClassification>
            <cbc:ItemClassificationCode listName="cpv">33696500</cbc:ItemClassificationCode>
         </cac:MainCommodityClassification>
         <cac:RealizedLocation>
            <cac:Address>
               <cbc:CountrySubentityCode listName="nuts">EL303</cbc:CountrySubentityCode>
               <cac:Country>
                  <cbc:IdentificationCode listName="country">GRC</cbc:IdentificationCode>
               </cac:Country>
            </cac:Address>
         </cac:RealizedLocation>
         <cac:PlannedPeriod>
            <cbc:DurationMeasure unitCode="YEAR">1</cbc:DurationMeasure>
         </cac:PlannedPeriod>
      </cac:ProcurementProject>
   </cac:ProcurementProjectLot>
</ContractNotice>